Inomax



Indications and Reactions:

Role Indications Reactions
Primary
Prophylaxis 28.6%
Pulmonary Hypertension 22.8%
Acute Respiratory Distress Syndrome 6.3%
Persistent Foetal Circulation 5.3%
Hypoxia 4.9%
Product Used For Unknown Indication 4.9%
Oxygen Saturation Decreased 4.4%
Pulmonary Arterial Hypertension 3.4%
Pulmonary Arterial Pressure Increased 2.9%
Respiratory Failure 2.4%
Sickle Cell Anaemia 2.4%
Neonatal Respiratory Distress Syndrome 1.9%
Bronchopulmonary Dysplasia 1.5%
Medical Device Implantation 1.5%
Premature Baby 1.5%
Ventricular Assist Device Insertion 1.5%
Acute Respiratory Failure 1.0%
Congenital Diaphragmatic Hernia 1.0%
Lung Disorder 1.0%
Myocardial Infarction 1.0%
Oxygen Saturation Decreased 21.8%
Device Failure 11.3%
Death 7.5%
Cardio-respiratory Arrest 6.8%
Patent Ductus Arteriosus 6.8%
Device Malfunction 4.5%
General Physical Health Deterioration 4.5%
Intraventricular Haemorrhage Neonatal 3.8%
Pulmonary Haemorrhage 3.8%
Cardiac Arrest 3.0%
Cognitive Disorder 3.0%
Drug Ineffective 3.0%
Off Label Use 3.0%
Respiratory Failure 3.0%
Sepsis Neonatal 3.0%
Hypotension 2.3%
Neonatal Disorder 2.3%
Neonatal Hypotension 2.3%
No Therapeutic Response 2.3%
Pneumothorax 2.3%
Secondary
Pulmonary Hypertension 36.0%
Prophylaxis 10.0%
Hypoxia 8.0%
Oxygen Saturation Decreased 8.0%
Product Used For Unknown Indication 6.0%
Acute Respiratory Distress Syndrome 4.0%
Acute Respiratory Failure 4.0%
Neonatal Aspiration 4.0%
Neonatal Respiratory Distress Syndrome 4.0%
Oxygen Supplementation 4.0%
Persistent Foetal Circulation 4.0%
Bronchopulmonary Dysplasia 2.0%
Lung Disorder 2.0%
Pulmonary Arterial Pressure Increased 2.0%
Venous Oxygen Saturation 2.0%
Oxygen Saturation Decreased 35.0%
Device Failure 17.5%
Medical Device Complication 5.0%
Sepsis 5.0%
Cardio-respiratory Arrest 2.5%
Central Venous Pressure Increased 2.5%
Congenital Cystic Kidney Disease 2.5%
Device Malfunction 2.5%
Device Misuse 2.5%
Disease Progression 2.5%
Drug Administration Error 2.5%
Hypotension 2.5%
Multi-organ Failure 2.5%
Neonatal Disorder 2.5%
Neonatal Hypoxia 2.5%
Patent Ductus Arteriosus 2.5%
Renal Disorder 2.5%
Ventricular Fibrillation 2.5%
White Blood Cell Count Decreased 2.5%
Concomitant
Pulmonary Hypertension 20.0%
Prophylaxis 16.0%
Arrhythmia 8.0%
Hypotension 8.0%
Product Used For Unknown Indication 8.0%
Sedation 8.0%
Analgesic Therapy 4.0%
Cardiac Disorder 4.0%
Cardiac Failure High Output 4.0%
Cardiac Output 4.0%
Coronary Artery Bypass 4.0%
Patent Ductus Arteriosus 4.0%
Tardive Dyskinesia 4.0%
Ventricular Assist Device Insertion 4.0%
Renal Failure 25.0%
Ill-defined Disorder 12.5%
Post Procedural Haemorrhage 12.5%
Pulmonary Hypertension 12.5%
Pulmonary Interstitial Emphysema Syndrome 12.5%
Respiratory Acidosis 12.5%
Therapy Non-responder 12.5%